Home | Articles
Published on:June 2021
Indian Journal of Pharmaceutical Education and Research, 2021; 55(2s):s448-s456
Original Article | doi:10.5530/ijper.55.2s.116

Proof-of-concept for Site-specific Delivery of Mesalamine Nanoparticles for Effective Therapy in Colitis


Authors and affiliation (s):

Nagaraja Sreeharsha1,3,*, Rashmi Narayan2, Joshi Vijaya2, Anroop Nair1

1Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa, SAUDI ARABIA.

2Department of Pharmaceutics, Government College of Pharmacy, Bangalore, Karnataka, INDIA.

3Department of Pharmaceutics, Vidya Siri College of Pharmacy, Off. Sarjapura Road, Bangalore, Karnataka, INDIA.

Abstract:

Background: Mesalamine loaded polymeric nanoparticles were prepared using three different polymers namely, Eudragit RS100, PLGA (50:50), or Eudragit RLPO, with an aim of targeted delivery to the inflamed colon. Materials and Methods: Nanoparticles were prepared by modified emulsification solvent evaporation and characterized for various physicochemical characteristics viz., size, size distribution, mesalamine entrapment, and in-vitro release. Results: Amongst the various formulations prepared, formulation F5 mesalamine nanoparticles made with Eudragit RS100 showed drug entrapment of 72.09% with comparative discrete nearing spherical particle size of 200 nm. In-vivo targeting potential of nanoparticles to the inflamed tissue was evaluated in acetic acid-induced colitis rat model and efficacy was compared with pristine mesalamine powder. Biochemical estimations were carried in colonic tissue homogenate to check the oxidative damage. The myeloperoxidase activity and lipid peroxides were significantly decreased and glutathione content increased after the oral administration of mesalamine nanoparticles compared to pure drug mesalamine. Conclusion: This delivery system enabled the drug to accumulate in the inflamed tissue with higher efficiency than the pure drug thus nanoparticulate system was efficient in mitigating the experimental colitis.

Key words: Nanoparticles, Mesalamine, Inflammatory Bowel Disease, Eudragit RS100, PLGA, Eudragit RLPO.

 




 

Impact Factor

IJPER - An Official Publication of Association of Pharmaceutical Teachers of India is pleased to announce continued growth in the 2019 Release of Journal Citation Reports (source: 2018 Web of Science Data).

 

Impact Factor® as reported in the 2018 Journal Citation Reports® (Clarivate Analytics, 2019): 0.425

The Official Journal of Association of Pharmaceutical Teachers of India (APTI)
(Registered under Registration of Societies Act XXI of 1860 No. 122 of 1966-1967, Lucknow)

Indian Journal of Pharmaceutical Education and Research (IJPER) [ISSN-0019-5464] is the official journal of Association of Pharmaceutical Teachers of India (APTI) and is being published since 1967.

DOI HISTORY

IJPER uses reference linking service using Digital Object Identifiers (DOI) by Crossref. Articles from the year 2013 are being assigned DOIs for its permanent URLs